Great Tree Pharmacy Co., Ltd. (TPEX:6469)
Taiwan · Delayed Price · Currency is TWD 76.40
-1.20 (-1.55%)
May 8, 2026, 1:30 PM CST
Great Tree Pharmacy Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 19,069 | 18,896 | 17,274 | 16,144 | 14,565 | 11,281 | |
Revenue Growth (YoY) | 7.52% | 9.39% | 7.00% | 10.84% | 29.11% | 30.55% |
Cost of Revenue | 13,600 | 13,479 | 12,432 | 11,658 | 10,554 | 8,338 |
Gross Profit | 5,468 | 5,417 | 4,843 | 4,486 | 4,011 | 2,943 |
Selling, General & Admin | 4,840 | 4,727 | 4,041 | 3,680 | 3,149 | 2,451 |
Operating Expenses | 4,840 | 4,727 | 4,041 | 3,680 | 3,149 | 2,451 |
Operating Income | 627.98 | 689.33 | 801.19 | 805.56 | 861.87 | 492.31 |
Interest Expense | -93.08 | -85.83 | -58.9 | -57.5 | -45.85 | -35.13 |
Interest & Investment Income | 44.31 | 38.56 | 13.27 | 15.88 | 4.32 | 0.74 |
Earnings From Equity Investments | -1.3 | -1.16 | -0.79 | -0.93 | - | - |
Currency Exchange Gain (Loss) | -0.51 | -0.51 | 3.73 | 1.53 | 12.54 | -1.86 |
Other Non Operating Income (Expenses) | 108.42 | 96.09 | 83.46 | 76.01 | 48.25 | 50.91 |
EBT Excluding Unusual Items | 685.81 | 736.49 | 841.95 | 840.55 | 881.14 | 506.97 |
Gain (Loss) on Sale of Investments | 0.7 | 0.7 | 4.39 | -0.72 | -0.43 | - |
Gain (Loss) on Sale of Assets | 5.56 | 5.56 | 0.42 | 0.5 | 1.12 | 0.1 |
Other Unusual Items | 1.24 | 1.24 | - | 1.49 | 0.5 | 2.6 |
Pretax Income | 693.31 | 743.99 | 846.77 | 841.82 | 882.33 | 509.67 |
Income Tax Expense | 147.62 | 162.49 | 166.8 | 175.34 | 181.83 | 101.91 |
Earnings From Continuing Operations | 545.69 | 581.5 | 679.96 | 666.48 | 700.5 | 407.76 |
Minority Interest in Earnings | 20.12 | 18.92 | 0.8 | -0.44 | -0.43 | -0.34 |
Net Income | 565.81 | 600.42 | 680.77 | 666.05 | 700.07 | 407.42 |
Net Income to Common | 565.81 | 600.42 | 680.77 | 666.05 | 700.07 | 407.42 |
Net Income Growth | -15.76% | -11.80% | 2.21% | -4.86% | 71.83% | 109.67% |
Shares Outstanding (Basic) | 150 | 150 | 149 | 147 | 145 | 143 |
Shares Outstanding (Diluted) | 150 | 158 | 154 | 155 | 150 | 148 |
Shares Change (YoY) | -2.98% | 2.67% | -0.75% | 3.19% | 1.51% | 3.36% |
EPS (Basic) | 3.78 | 4.01 | 4.57 | 4.54 | 4.83 | 2.86 |
EPS (Diluted) | 3.78 | 3.89 | 4.51 | 4.40 | 4.70 | 2.76 |
EPS Growth | -14.57% | -13.63% | 2.40% | -6.35% | 70.41% | 100.79% |
Free Cash Flow | 801.11 | 839.12 | 779.64 | 594.08 | 924.01 | 829.21 |
Free Cash Flow Per Share | 5.35 | 5.32 | 5.08 | 3.84 | 6.16 | 5.61 |
Dividend Per Share | 3.160 | 3.160 | 2.921 | 2.724 | 2.895 | 1.260 |
Dividend Growth | 8.28% | 8.19% | 7.24% | -5.93% | 129.89% | 233.29% |
Gross Margin | 28.68% | 28.67% | 28.03% | 27.79% | 27.54% | 26.09% |
Operating Margin | 3.29% | 3.65% | 4.64% | 4.99% | 5.92% | 4.36% |
Profit Margin | 2.97% | 3.18% | 3.94% | 4.13% | 4.81% | 3.61% |
Free Cash Flow Margin | 4.20% | 4.44% | 4.51% | 3.68% | 6.34% | 7.35% |
EBITDA | 912.9 | 959.39 | 1,069 | 1,046 | 1,071 | 663.11 |
EBITDA Margin | 4.79% | 5.08% | 6.19% | 6.48% | 7.35% | 5.88% |
D&A For EBITDA | 284.92 | 270.06 | 268.1 | 240.04 | 208.92 | 170.8 |
EBIT | 627.98 | 689.33 | 801.19 | 805.56 | 861.87 | 492.31 |
EBIT Margin | 3.29% | 3.65% | 4.64% | 4.99% | 5.92% | 4.36% |
Effective Tax Rate | 21.29% | 21.84% | 19.70% | 20.83% | 20.61% | 19.99% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.